A new study by Burke Neurological Institute (BNI), Weill Cornell Medicine, finds that activation of MAP2K signaling by genetic engineering or non-invasive repetitive transcranial magnetic stimulation (rTMS) promotes corticospinal ...
Jan 5, 2023
0
192
Lung cancer is the deadliest cancer in the United States and around the world. Many of the currently available therapies have been ineffective, leaving patients with very few options. A promising new strategy to treat cancer ...
Dec 24, 2022
0
193
Medical insurance claims might do more than help pay for health concerns; they could help predict them, according to new findings from an interdisciplinary Penn State research team published in BMJ Health & Care Informatics. ...
Oct 11, 2022
0
31
Glioblastoma, the most common cancerous brain tumor in adults, is an aggressive disease—patients survive an average of just 15 months once they are diagnosed. Despite more than two decades of research on the causes and ...
Sep 26, 2022
1
59
Researchers and entrepreneurs have developed an implant made of collagen protein from pig's skin, which resembles the human cornea. In a pilot study, the implant restored vision to 20 people with diseased corneas, most of ...
Aug 11, 2022
0
677
Researchers have created a photoacoustic imaging endoscope probe that can fit inside a medical needle with an inner diameter of just 0.6 millimeters. Photoacoustic imaging, which combines light and sound to create 3D images, ...
Jul 27, 2022
0
14
Some cytokines can enhance the production of aberrantly O-glycosylated IgA1, the main autoantigen in IgA nephropathy. The mechanism behind this observation is described in the Journal of Interferon & Cytokine Research (JICR).
Jul 19, 2022
0
5
A screening tool developed at the University of Strathclyde, U.K., could increase the number of tests on a solid tumor sample by up to 50 times.
Jun 21, 2022
0
47
A new study presents a novel approach to drug repurposing that incorporates two-stage prediction and machine learning. The study is published in the peer-reviewed OMICS: A Journal of Integrative Biology.
Jun 7, 2022
0
5
Western biomaterials expert Kibret Mequanint—in partnership with Malcolm Xing from University of Manitoba—has developed the first-ever hydrophobic (water-hating) fluid, which displaces body fluids surrounding an injury ...
May 23, 2022
1
173
